Table 2.
Patient characteristics, continuous variables. Divided into subgroups of hepatoblastoma and other primary liver malignancies as expressed using mean and standard deviation for whole group and sub-groups as well as median and range only for the whole group.
| Variable | pLTx for All Liver Tumours (n = 39) |
pLTx for Hepatoblastoma (n = 31) |
pLTx for Liver Tumours Other than Hepatoblastoma (n = 8) | p-Value | |||
|---|---|---|---|---|---|---|---|
| Mean (Median) |
SD (Range) | Mean | SE | Mean | SE | ||
| Age at diagnosis | 3.35 (1.69) | 3.45 (0.28–12.12) | 2.73 | 3.05 | 5.74 | 4.07 | 0.0129 |
| Age at pLTx [years] | 4.05 (2.59) | 3.69 (0.56–14.34) | 3.35 | 3.05 | 6.77 | 4.86 | 0.0088 |
| Time between diagnosis and pLTx [years] | 0.72 (0.47) | 0.76 (0.05–4.00) | 0.62 | 0.27 | 1.03 | 0.27 | 0.1912 |
| Weight at pLTx [kg] | 17.01 (12.15) | 11.65 (7.3–60.0) | 14.70 | 1.92 | 27.25 | 4.04 | 0.0081 |
| Height at pLTx [cm] | 96.4 (86.5) | 25.7 (63–169) | 92.6 | 4.44 | 113.0 | 9.35 | 0.0282 |
| BMI [kg/m2] | 16.75 (16.51) | 2.17 (13.0–23.5) | 16.25 | 0.34 | 19.01 | 0.72 | 0.0014 |
| AFP maximum [IU/L] | n/a | 541,945 (338,065) | 717,927 (526–3,114,000) | n/a | |||
| AFP at pLTx [IU/L] | 48,458 (108) | 251,033 (2–1,400,000) | |||||
| AFP max/AFP LTx | 9270 (719.9) | 17,034 (1.33–60,000) | |||||
| Creatinine at pLTx [µmol/L] | 47.3 (27) | 112.9 (10–692) | 34.2 | 46.7 | 50.0 | 21.2 | 0.7594 |
| Bilirubine at pLTx [µmol/L] | 21 (5) | 68 (3–390) | 23.1 | 12.8 | 9.0 | 30.8 | 0.6757 |
| Albumine at pLTx (g/L) | 39.4 (40) | 5.6 (25–48) | 39.5 | 1.08 | 39.0 | 2.86 | 0.8742 |
| INR at pLTx | 1.12 (1.13) | 0.14 (0.9–1.69) | 1.12 | 0.03 | 1.10 | 0.07 | 0.8063 |
| Waiting time for pLTx all status [days] | 41.2 (37) | 16.7 (2–127) | 36.9 | 9.59 | 55.5 | 35.9 | 0.3613 |
| Waiting time for pLTx on high urgency (HU) list (only HU patients) [days] | 9.72 (9) | 7.1 (0–23) | 10.17 | 1.35 | 8.12 | 2.53 | 0.4795 |
| ICU stay post pLtx [days] | 9.07 (6) | 12.3 (1–65) | 9.20 | 2.79 | 8.71 | 4.72 | 0.9301 |
| NON-ICU stay post Ltx [days] | 26.44 (22) | 16.23 (0–68) | 25.70 | 3.69 | 28.57 | 6.24 | 0.6953 |
| Follow-up after pLTx [years] | 9.49 (7.97) | 9.14 (0.84–36.76) | 7.59 | 1.46 | 16.87 | 2.86 | 0.0064 |
| Follow-up after diagnosis [years] | 10.20 (9.49) | 8.84 (0.28–34.08) | 8.21 | 1.50 | 17.89 | 2.95 | 0.0059 |